Breaking News Instant updates and real-time market news.

NGLOY

Anglo American

$0.00 /

+ (+0.00%)

04:55
09/12/19
09/12
04:55
09/12/19
04:55

Anglo American management to meet with Morgan Stanley

Meetings to be held in New York on September 10 in Boston on September 11 and in Chicago/Toronto on September 12 hosted by Morgan Stanley.

  • 12

    Sep

NGLOY Anglo American
$0.00 /

+ (+0.00%)

05/28/19 HSBC
Anglo American upgraded to Buy from Hold at HSBC
05/24/19 RBC Capital
Anglo American upgraded to Top Pick from Outperform at RBC Capital
05/22/19 Societe Generale
Anglo American upgraded to Buy from Hold at Societe Generale
05/17/19 Liberum
Anglo American upgraded to Buy from Hold at Liberum

TODAY'S FREE FLY STORIES

Hot Stocks
ACI Worldwide appoints Alvaro Monserrat as chief revenue officer » 08:06
08/10/20
08/10
08:06
08/10/20
08:06
ACIW

ACI Worldwide

$30.51 /

-0.43 (-1.39%)

ACI Worldwide announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACIW ACI Worldwide
$30.51 /

-0.43 (-1.39%)

ACIW ACI Worldwide
$30.51 /

-0.43 (-1.39%)

08/07/20 Canaccord
ACI Worldwide price target raised to $40 from $35 at Canaccord
07/07/20 Canaccord
ACI Worldwide product portfolio increases confidence, says Canaccord
05/29/20 Needham
ACI Worldwide initiated with a Buy at Needham
05/08/20 Canaccord
ACI Worldwide price target lowered to $35 from $44 at Canaccord
ACIW ACI Worldwide
$30.51 /

-0.43 (-1.39%)

Initiation
nCino initiated with a Market Perform at Raymond James » 08:05
08/10/20
08/10
08:05
08/10/20
08:05
NCNO

nCino

$75.71 /

+0.21 (+0.28%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NCNO nCino
$75.71 /

+0.21 (+0.28%)

07:18 Today Truist
nCino initiated with a Buy at Truist
06:59 Today Raymond James
nCino initiated with a Market Perform at Raymond James
06:57 Today KeyBanc
KeyBanc bullish on nCino, initiates with an Overweight
06:19 Today BofA
nCino initiated with a Buy at BofA
  • 14
    Jul
NCNO nCino
$75.71 /

+0.21 (+0.28%)

NCNO nCino
$75.71 /

+0.21 (+0.28%)

Initiation
AutoCanada transferred with a Buy at Stifel » 08:05
08/10/20
08/10
08:05
08/10/20
08:05
AOCIF

AutoCanada

$0.00 /

+ (+0.00%)

Stifel GMP analyst Maggie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AOCIF AutoCanada
$0.00 /

+ (+0.00%)

07/27/20 Scotiabank
AutoCanada price target raised to C$18.50 from C$13 at Scotiabank
04/21/20 Canaccord
AutoCanada price target lowered to C$8 from C$12 at Canaccord
04/13/20 CIBC
AutoCanada downgraded to Underperformer from Neutral at CIBC
04/13/20 CIBC
AutoCanada downgraded to Underperformer from Neutral at CIBC
Hot Stocks
Royal Caribbean says FY20 bookings 'meaningfully lower' than prior year » 08:05
08/10/20
08/10
08:05
08/10/20
08:05
RCL

Royal Caribbean

$52.15 /

+1.04 (+2.03%)

The extended suspension…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

07/14/20
Fly Intel: Top five analyst downgrades
07/14/20 SunTrust
Cruise Line operators downgraded at SunTrust on delayed starting dates
07/14/20 SunTrust
Royal Caribbean downgraded to Hold from Buy at SunTrust
07/14/20 Macquarie
Royal Caribbean downgraded to Neutral from Outperform at Macquarie
RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

Earnings
Cellectar Biosciences reports Q2 EPS (26c), consensus (30c) » 08:04
08/10/20
08/10
08:04
08/10/20
08:04
CLRB

Cellectar Biosciences

$1.40 /

+0.01 (+0.72%)

"We continue to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLRB Cellectar Biosciences
$1.40 /

+0.01 (+0.72%)

CLRB Cellectar Biosciences
$1.40 /

+0.01 (+0.72%)

07/01/20 Oppenheimer
Oppenheimer bullish on Cellectar Biosciences, initiates with an Outperform
07/01/20 Oppenheimer
Cellectar Biosciences initiated with an Outperform at Oppenheimer
06/23/20
Fly Intel: Top five analyst initiations
06/23/20 Maxim
Cellectar Biosciences initiated with a Buy at Maxim
CLRB Cellectar Biosciences
$1.40 /

+0.01 (+0.72%)

Periodicals
Roper Technologies in talks to buy Vertafore for $5.5B, Reuters reports » 08:03
08/10/20
08/10
08:03
08/10/20
08:03
ROP

Roper Technologies

$440.84 /

+3.825 (+0.88%)

Roper Technologies is in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ROP Roper Technologies
$440.84 /

+3.825 (+0.88%)

ROP Roper Technologies
$440.84 /

+3.825 (+0.88%)

07/29/20 Wells Fargo
Roper Technologies price target raised to $490 from $475 at Wells Fargo
07/29/20 Argus
Roper Technologies price target raised to $475 from $400 at Argus
06/12/20 Oppenheimer
Roper Technologies downgraded at Oppenheimer after shares eclipse price target
06/11/20 Oppenheimer
Roper Technologies downgraded to Perform from Outperform at Oppenheimer
ROP Roper Technologies
$440.84 /

+3.825 (+0.88%)

ROP Roper Technologies
$440.84 /

+3.825 (+0.88%)

Earnings
Royal Caribbean sees Q3, FY20 net loss » 08:03
08/10/20
08/10
08:03
08/10/20
08:03
RCL

Royal Caribbean

$52.15 /

+1.04 (+2.03%)

The magnitude, duration…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

07/14/20
Fly Intel: Top five analyst downgrades
07/14/20 SunTrust
Cruise Line operators downgraded at SunTrust on delayed starting dates
07/14/20 SunTrust
Royal Caribbean downgraded to Hold from Buy at SunTrust
07/14/20 Macquarie
Royal Caribbean downgraded to Neutral from Outperform at Macquarie
RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

Recommendations
Mirati Therapeutics price target raised to $133 from $105 at Oppenheimer » 08:03
08/10/20
08/10
08:03
08/10/20
08:03
MRTX

Mirati Therapeutics

$129.32 /

-0.52 (-0.40%)

Oppenheimer analyst Jay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$129.32 /

-0.52 (-0.40%)

MRTX Mirati Therapeutics
$129.32 /

-0.52 (-0.40%)

08/07/20 Barclays
Mirati Therapeutics price target raised to $143 from $123 at Barclays
05/01/20
Fly Intel: Top five analyst upgrades
05/01/20 JPMorgan
JPMorgan upgrades Mirati Therapeutics to Overweight on MRTX849 potential
05/01/20 JPMorgan
Mirati Therapeutics upgraded to Overweight from Neutral at JPMorgan
MRTX Mirati Therapeutics
$129.32 /

-0.52 (-0.40%)

  • 10
    Jan
MRTX Mirati Therapeutics
$129.32 /

-0.52 (-0.40%)

MRTX Mirati Therapeutics
$129.32 /

-0.52 (-0.40%)

Hot Stocks
Royal Caribbean estimates monthly cash burn $250M-$290M » 08:02
08/10/20
08/10
08:02
08/10/20
08:02
RCL

Royal Caribbean

$52.15 /

+1.04 (+2.03%)

The company estimates its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

07/14/20
Fly Intel: Top five analyst downgrades
07/14/20 SunTrust
Cruise Line operators downgraded at SunTrust on delayed starting dates
07/14/20 SunTrust
Royal Caribbean downgraded to Hold from Buy at SunTrust
07/14/20 Macquarie
Royal Caribbean downgraded to Neutral from Outperform at Macquarie
RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

Earnings
Royal Caribbean reports Q2 adjusted EPS ($6.13), consensus ($4.82) » 08:00
08/10/20
08/10
08:00
08/10/20
08:00
RCL

Royal Caribbean

$52.15 /

+1.04 (+2.03%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

07/14/20
Fly Intel: Top five analyst downgrades
07/14/20 SunTrust
Cruise Line operators downgraded at SunTrust on delayed starting dates
07/14/20 SunTrust
Royal Caribbean downgraded to Hold from Buy at SunTrust
07/14/20 Macquarie
Royal Caribbean downgraded to Neutral from Outperform at Macquarie
RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

Recommendations
Evofem price target raised to $25 from $18 at Oppenheimer » 08:00
08/10/20
08/10
08:00
08/10/20
08:00
EVFM

Evofem

$2.93 /

+0.025 (+0.86%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVFM Evofem
$2.93 /

+0.025 (+0.86%)

EVFM Evofem
$2.93 /

+0.025 (+0.86%)

06/09/20 H.C. Wainwright
Evofem price target lowered to $9 from $11 at H.C. Wainwright
06/08/20 Piper Sandler
Evofem initiated with an Overweight at Piper Sandler
04/16/20 Roth Capital
Roth believes Evofem 'underappreciated' ahead of Phexxi PDUFA date
12/18/19 Roth Capital
Evofem's Amphora getting closer to FDA approval, says Roth Capital
EVFM Evofem
$2.93 /

+0.025 (+0.86%)

  • 03
    Jun
EVFM Evofem
$2.93 /

+0.025 (+0.86%)

Hot Stocks
Hoth Therapeutics announces licensing of IP rights to COVID-19 testing device » 08:00
08/10/20
08/10
08:00
08/10/20
08:00
HOTH

Hoth Therapeutics

$2.77 /

-0.01 (-0.36%)

Hoth Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HOTH Hoth Therapeutics
$2.77 /

-0.01 (-0.36%)

HOTH Hoth Therapeutics
$2.77 /

-0.01 (-0.36%)

10/15/19 Benchmark
Hoth Therapeutics initiated with a Speculative Buy at Benchmark
  • 22
    May
HOTH Hoth Therapeutics
$2.77 /

-0.01 (-0.36%)

Hot Stocks
Kamada enrolls first patient in Phase 1/2 trial of IgG product » 08:00
08/10/20
08/10
08:00
08/10/20
08:00
KMDA

Kamada

$8.77 /

+0.05 (+0.57%)

Kamada announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KMDA Kamada
$8.77 /

+0.05 (+0.57%)

KMDA Kamada
$8.77 /

+0.05 (+0.57%)

KMDA Kamada
$8.77 /

+0.05 (+0.57%)

Options
Fiserv call buyer realizes 5% same-day gains » 08:00
08/10/20
08/10
08:00
08/10/20
08:00
FISV

Fiserv

$103.93 /

+1.55 (+1.51%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FISV Fiserv
$103.93 /

+1.55 (+1.51%)

FISV Fiserv
$103.93 /

+1.55 (+1.51%)

07/22/20 Barclays
Fiserv shares undervalued after 'clearing event,' says Barclays
07/14/20 Barclays
Fiserv pullback brings 'unique buying opportunity,' says Barclays
07/14/20 Goldman Sachs
Fiserv initiated with a Conviction Buy at Goldman Sachs
06/29/20 Oppenheimer
Fiserv downgraded to Perform at Oppenheimer
FISV Fiserv
$103.93 /

+1.55 (+1.51%)

FISV Fiserv
$103.93 /

+1.55 (+1.51%)

FISV Fiserv
$103.93 /

+1.55 (+1.51%)

Hot Stocks
New Pacific Metals graduates to TSX » 07:58
08/10/20
08/10
07:58
08/10/20
07:58
NUPMF

New Pacific Metals

$0.00 /

+ (+0.00%)

New Pacific Metals is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NUPMF New Pacific Metals
$0.00 /

+ (+0.00%)

NUPMF New Pacific Metals
$0.00 /

+ (+0.00%)

06/26/20 BMO Capital
New Pacific Metals price target raised to C$5.50 from C$4.50 at BMO Capital
01/06/20 BMO Capital
New Pacific Metals downgraded to Market Perform from Outperform at BMO Capital
08/13/19 BMO Capital
New Pacific Metals initiated with an Outperform at BMO Capital
NUPMF New Pacific Metals
$0.00 /

+ (+0.00%)

Recommendations
Mohawk price target raised to $90 from $75 at Loop Capital » 07:57
08/10/20
08/10
07:57
08/10/20
07:57
MHK

Mohawk

/

+

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MHK Mohawk
/

+

MHK Mohawk
/

+

07/28/20 Wells Fargo
Mohawk investigation adds 'layer of legitimacy' to lawsuit, says Wells Fargo
07/21/20 Loop Capital
Mohawk price target lowered to $75 from $90 at Loop Capital
07/14/20 Wells Fargo
Mohawk price target lowered to $70 from $80 at Wells Fargo
07/10/20 Jefferies
Mohawk could see short-lived relief rally after flooring data, says Jefferies
MHK Mohawk
/

+

MHK Mohawk
/

+

MHK Mohawk
/

+

MHK Mohawk
/

+

Recommendations
Rheinmetall named Catalyst Call Buy idea at Deutsche Bank » 07:57
08/10/20
08/10
07:57
08/10/20
07:57
RNMBY

Rheinmetall

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RNMBY Rheinmetall
$0.00 /

+ (+0.00%)

08/07/20 Deutsche Bank
Rheinmetall price target raised to EUR 100 from EUR 80 at Deutsche Bank
08/07/20 Oddo BHF
Rheinmetall upgraded to Buy from Neutral at Oddo BHF
05/13/20 Morgan Stanley
Rheinmetall price target raised to EUR 85 from EUR 82 at Morgan Stanley
05/11/20 Oddo BHF
Rheinmetall downgraded to Neutral from Buy at Oddo BHF
Hot Stocks
Aquestive Therapeutics receives Fast Track designation for AQST-108 » 07:57
08/10/20
08/10
07:57
08/10/20
07:57
AQST

Aquestive Therapeutics

$6.29 /

+0.23 (+3.80%)

Aquestive Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AQST Aquestive Therapeutics
$6.29 /

+0.23 (+3.80%)

AQST Aquestive Therapeutics
$6.29 /

+0.23 (+3.80%)

05/22/20 H.C. Wainwright
Aquestive Therapeutics price target raised to $15 from $13 at H.C. Wainwright
03/16/20 Wedbush
Aquestive Therapeutics price target lowered to $31 from $36 at Wedbush
02/10/20 Wedbush
Wedbush delays launch estimates for Libervant, ups Aquestive Therapeutics target
02/10/20 Wedbush
Aquestive price target raised to $36 at Wedbush after FDA accepts NDA
AQST Aquestive Therapeutics
$6.29 /

+0.23 (+3.80%)

  • 13
    Dec
AQST Aquestive Therapeutics
$6.29 /

+0.23 (+3.80%)

Recommendations
Carvana price target raised to $250 from $127 at Oppenheimer » 07:56
08/10/20
08/10
07:56
08/10/20
07:56
CVNA

Carvana

$191.81 /

-31.26 (-14.01%)

Oppenheimer analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVNA Carvana
$191.81 /

-31.26 (-14.01%)

CVNA Carvana
$191.81 /

-31.26 (-14.01%)

08/07/20
Fly Intel: Top five analyst downgrades
08/07/20 BofA
Carvana downgraded to Neutral from Buy at BofA
08/07/20 BofA
Carvana downgraded to Neutral from Buy at BofA
08/06/20 Wells Fargo
Carvana price target raised to $200 from $175 at Wells Fargo
CVNA Carvana
$191.81 /

-31.26 (-14.01%)

  • 19
    May
CVNA Carvana
$191.81 /

-31.26 (-14.01%)

CVNA Carvana
$191.81 /

-31.26 (-14.01%)

CVNA Carvana
$191.81 /

-31.26 (-14.01%)

Hot Stocks
Ocugen receives Orphan Drug designation for OCU400 gene therapy » 07:56
08/10/20
08/10
07:56
08/10/20
07:56
OCGN

Ocugen

$0.55 /

+0.0904 (+19.77%)

Ocugen announced the U.S.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCGN Ocugen
$0.55 /

+0.0904 (+19.77%)

OCGN Ocugen
$0.55 /

+0.0904 (+19.77%)

06/01/20 H.C. Wainwright
H.C. Wainwright downgrades Ocugen to Neutral after OCU300 discontinuation
06/01/20 H.C. Wainwright
Ocugen downgraded to Neutral from Buy at H.C. Wainwright
03/30/20 H.C. Wainwright
H.C. Wainwright encouraged Ocugen's Phase 3 trial of OCU300 still on track
12/20/19 H.C. Wainwright
Ocugen initiated with a Buy at H.C. Wainwright
OCGN Ocugen
$0.55 /

+0.0904 (+19.77%)

OCGN Ocugen
$0.55 /

+0.0904 (+19.77%)

Recommendations
Wix.com price target raised to $342 from $220 at Deutsche Bank » 07:55
08/10/20
08/10
07:55
08/10/20
07:55
WIX

Wix.com

$291.82 /

-15.89 (-5.16%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WIX Wix.com
$291.82 /

-15.89 (-5.16%)

WIX Wix.com
$291.82 /

-15.89 (-5.16%)

08/07/20 Oppenheimer
Wix.com price target raised to $350 from $305 at Oppenheimer
08/07/20 JMP Securities
Wix.com price target raised to $363 from $210 at JMP Securities
07/23/20 Citi
Wix.com price target raised to $330 from $220 at Citi
07/22/20 KeyBanc
Wix.com price target raised to $325 from $275 at KeyBanc
WIX Wix.com
$291.82 /

-15.89 (-5.16%)

WIX Wix.com
$291.82 /

-15.89 (-5.16%)

WIX Wix.com
$291.82 /

-15.89 (-5.16%)

Conference/Events
Goldman Sachs consumer goods analyst to hold an analyst/industry webcast » 07:55
08/10/20
08/10
07:55
08/10/20
07:55

Consumer Goods Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Amazon.com price target raised to $3,775 from $2,900 at Loop Capital » 07:54
08/10/20
08/10
07:54
08/10/20
07:54
AMZN

Amazon.com

$3,167.40 /

-54.81 (-1.70%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

08/07/20 DA Davidson
Datadog price target raised to $80 from $52 at DA Davidson
08/03/20 Morgan Stanley
ADT Inc. price target raised to $17 from $7 at Morgan Stanley
07/31/20 BMO Capital
Amazon.com price target raised to $3,700 from $3,500 at BMO Capital
07/31/20 RBC Capital
Amazon.com price target raised to $3,800 from $3,300 at RBC Capital
AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

Earnings
Front Yard Residential reports Q2 AFFO 9c, consensus 10c » 07:53
08/10/20
08/10
07:53
08/10/20
07:53
RESI

Front Yard Residential

$9.14 /

+0.245 (+2.76%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RESI Front Yard Residential
$9.14 /

+0.245 (+2.76%)

RESI Front Yard Residential
$9.14 /

+0.245 (+2.76%)

06/12/20 Northland
Front Yard Residential upgraded to Outperform from Market Perform at Northland
06/08/20 JMP Securities
Front Yard upgraded to Outperform from Market Perform at JMP Securities
05/18/20 Credit Suisse
Front Yard Residential reinstated with an Outperform at Credit Suisse
02/19/20 Northland
Front Yard Residential downgraded to Market Perform from Outperform at Northland
RESI Front Yard Residential
$9.14 /

+0.245 (+2.76%)

Recommendations
Apple price target raised to $480 from $440 at Deutsche Bank » 07:53
08/10/20
08/10
07:53
08/10/20
07:53
AAPL

Apple

$444.41 /

-10.98 (-2.41%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$444.41 /

-10.98 (-2.41%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

07:26 Today Wedbush
Apple price target raised to $515 from $475 at Wedbush
07:02 Today KeyBanc
Survey indicates strengthening recovery in Apple iPhone sales, says KeyBanc
08/06/20 KeyBanc
Synaptics upgraded to Overweight from Sector Weight at KeyBanc
08/06/20 Barclays
SiTime price target raised to $75 from $50 at Barclays
AAPL Apple
$444.41 /

-10.98 (-2.41%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.